Moneycontrol Be a Pro
Get App
Last Updated : Jul 14, 2016 04:35 PM IST | Source: CNBC-TV18

Brooks Lab gains 33% in last 4 sessions; 60% since March '16

The company is into contract manufacturing specializing in injectable molecules and clavulanic acid range in tablets and dry syrups.


The micro-cap stock which has been buzzing in trade is Brooks Lab. The stock has risen 33 percent in last four trading session and 60 percent since March 2016.


The company is into contract manufacturing specializing in injectable molecules and clavulanic acid range in tablets and dry syrups.

The company boasts of clients like Cadila and Zydus.

Watch the video to know more about the stock 

Close


Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.
First Published on Jul 14, 2016 04:35 pm
Loading...
Sections
Follow us on
Available On